Quality key factors
Factor
Value
Sales Growth (5y)
7.68%
EBIT Growth (5y)
-6.71%
EBIT to Interest (avg)
11.07
Debt to EBITDA (avg)
1.02
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
1.03
Tax Ratio
4.98%
Dividend Payout Ratio
37.06%
Pledged Shares
0
Institutional Holding
20.12%
ROCE (avg)
11.33%
ROE (avg)
10.96%
Valuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
37
Price to Book Value
2.84
EV to EBIT
21.01
EV to EBITDA
14.86
EV to Capital Employed
2.52
EV to Sales
2.23
PEG Ratio
0.79
Dividend Yield
1.46%
ROCE (Latest)
11.59%
ROE (Latest)
12.93%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
Bullish
Technical Movement
7What is working for the Company
PAT(Latest six months)
At Rs 400.53 cr has Grown at 28.68%
NET SALES(Q)
Highest at Rs 2,149.77 cr
PBDIT(Q)
Highest at Rs 331.86 cr.
-3What is not working for the Company
INTEREST(Q)
Highest at Rs 27.61 cr
Loading Valuation Snapshot...
Here's what is working for Alembic Pharma
Profit After Tax (PAT) - Latest six months
At Rs 400.53 cr has Grown at 28.68%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 2,149.77 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 2,149.77 cr has Grown at 25.66%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 331.86 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Here's what is not working for Alembic Pharma
Interest - Quarterly
Highest at Rs 27.61 cr
in the last five quarters and Increased by 22.38 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)